Gisele Dion
Director/Board Member bij CYTEK BIOSCIENCES, INC.
Vermogen: 33 550 $ op 31-03-2024
Profiel
Gisele Dion is currently the Director at Inhibikase Therapeutics, Inc. and an Independent Director at Cytek Biosciences, Inc. She previously worked as the Senior Director-Technical Accounting & Controller at Biogen, Inc. from 2007 to 2016, and as the Chief Accounting Officer at Shire Plc from 2017 to 2019.
She also served as the Chief Accounting Officer, Senior VP & Controller at Takeda Pharmaceutical Co., Ltd.
from 2019 to 2021, and at Shire Pharmaceuticals LLC from 2016 to 2019.
Ms. Dion received her undergraduate degree from Fairfield University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CYTEK BIOSCIENCES, INC.
0.00% | 14-06-2023 | 5 000 ( 0.00% ) | 33 550 $ | 31-03-2024 |
| 01-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Gisele Dion
| Bedrijven | Functie | Begin |
|---|---|---|
| CYTEK BIOSCIENCES, INC. | Director/Board Member | 01-03-2021 |
| INHIBIKASE THERAPEUTICS, INC. | Director/Board Member | 01-09-2022 |
Eerdere bekende functies van Gisele Dion
| Bedrijven | Functie | Einde |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Comptroller/Controller/Auditor | 01-03-2021 |
| SHIRE | Comptroller/Controller/Auditor | 01-01-2019 |
Shire Pharmaceuticals LLC
 Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Comptroller/Controller/Auditor | 01-01-2019 |
| BIOGEN INC. | Comptroller/Controller/Auditor | 01-01-2016 |
Opleiding van Gisele Dion
| Fairfield University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Cytek Biosciences, Inc. | |
Shire Pharmaceuticals LLC
Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Health Technology |
